{"name":"Syntimmune, Inc.","slug":"syntimmune-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOc3hMUFJxLXF1dWo3MTNEay1oNEs5NE14Y1N6clZIWTR5UThOakg4c0xXODc4WnV5TzNkb3duT2RRdXpIaGVWckFKdElJbFB0S2lnSmxhcHBWNnFjOWNrZzI5SXo1TG5qc0VJZG1QbEVvdVV6MjJhaHUxZjBvU1NmZm1UbULSAVZBVV95cUxNZ2J4RGhXZ0hBMlV0ZmQtaWh6NkkzYU14YURPU25SZ1p3TkZZcGFna3h2ZUhIVjVfbFI0ZHozMFQtZ0dGWXVBc2gwYmpYMjJwRWZ1WEFYQQ?oc=5","date":"2026-02-27","type":"regulatory","source":"Law360","summary":"Trials Group Of The Year: Quinn Emanuel - Law360","headline":"Trials Group Of The Year: Quinn Emanuel - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQZ0lTOU9OZUhHVzJ5SmR2UW11X0RGT053c3NZOFpnQmZDZjZJTDBJZHVVZG5JS0ZIdkp6N3ZDVkc2SmlOZXlueGZhRFZnS1Zzb3BSOWgtN2VYMXlSbGthOFlKLVQtbjl5Y0tVTk1tSG9oRTJBMklxcFlzT0xGZFl5MVowc3IxZE40cF9mRmdYWkx0a3hZMk1DUUw2NUlCTlXSAVZBVV95cUxPQ2xMN1Q0YkRMZTVOcDZaTXNrd2VqUGkza0d3YVZ4Qkh5aVEtVU5qbXhQYlZXMGhlM2tzRVc4R0xTNGVFNFR4eWtTR192LWRkUnV5WWVPZw?oc=5","date":"2025-08-12","type":"deal","source":"Law360","summary":"AstraZeneca, Stockholders Far Apart In Merger Damages Tally - Law360","headline":"AstraZeneca, Stockholders Far Apart In Merger Damages Tally - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNeUloenZEb1IxYUhidy1fRjV4ek51UWFyamhIRFBPdTMwc3RwUXkwVGtTWFFUcnJudG5PRjRIWmRSWmFBREt6Y2tEWVR4N1VpMkdWM1daOThxSk1mTTVEZHNwMEFGbjc3NWJVZWxNQnpCR3lJelNqTGljeFRWRDFQWnJ1U2ktNjRxb1lXQVREUlNDa3Q2a2owM085VzFWUmpjVXZhMEFEMVpZT3FfZW9WNm9scHhtM1VG?oc=5","date":"2025-06-12","type":"pipeline","source":"Fierce Pharma","summary":"AstraZeneca takes $181M hit in Syntimmune shareholder lawsuit on top of previous $130M award - Fierce Pharma","headline":"AstraZeneca takes $181M hit in Syntimmune shareholder lawsuit on top of previous $130M award","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNYXZHc1NQNl9CUnVURGVqQU5QZ19pX05UWVZLc0lVaVo4VkJsUEJrNE9TaTc5WXp3RVp1V25RZmdqaHJHazZyX25YaEZEdk9aWHZUMTJlM0RtRjIxaVJOWm5Xam9QRHU3UEtWTXVTWEl5N1NsNzYxZE9yTGpuTHBYZmF1OVp4VmFqS3dST19CR09rRW9VaXBuemNTQXZZOUNOQVgxUW1lMm04a0piX3lkekhEcmV2YUE?oc=5","date":"2024-10-11","type":"pipeline","source":"Osborne Clarke","summary":"'Commercially reasonable efforts' in licensing agreements: what needs to be considered? - Osborne Clarke","headline":"'Commercially reasonable efforts' in licensing agreements: what needs to be considered?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPdmEyaGNEbFNFLTJrTEMzaUwwWmNsTllOTTU5a0FVR0I2bkx0TWVYZ0pxNTRKa3cwamZuWlhDMVVFVlpCYnpoSDdPaHBBSlhxbXJfbVZoRF9Scmh1VTlPbDJTUEFIMnZZSE9pcE9CMHpnMEhBTHFGTG9LaGVrYy1vVjdTMEFWdk03NndGOUt2Sk9lY3RaZW8yLWV5SEtWU3N5M3gwZ1B1VlVDNzNxUnlKNnAyaG5kbDN3dFM4?oc=5","date":"2024-09-09","type":"deal","source":"Fierce Pharma","summary":"AstraZeneca's Alexion loses $130M to Syntimmune shareholders in post-merger payment suit - Fierce Pharma","headline":"AstraZeneca's Alexion loses $130M to Syntimmune shareholders in post-merger payment suit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPRUdUNDFTT2F0S3MybE9WYWRXWFlnTy1jckJPN04yOWl5ZEhDektHRmRfQ0JobU1fMjVjZ1QwMlA5dnNZQWYwbzY4Ylp5R0pMOFdmSHFlOWNsSExSeWxUZ1g5dndMSFZxWmRFODMtVVU0dXc3R2hobDFqOGhnOHFSdmpFWURtT2dXMjdrRWFMRmFtdTNaQ3E4VWxjakhJRWNXbi14cGh5TTVPNHZVcG5sOVFOa25ZV2lPc1E?oc=5","date":"2018-11-06","type":"pipeline","source":"Hartford Business Journal","summary":"Alexion completes $1.2B acquisition; Hamden startup launches tissue-freezing device - Hartford Business Journal","headline":"Alexion completes $1.2B acquisition; Hamden startup launches tissue-freezing device","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOQm5jdXpaU25yd21CY1hMYlJYeWdHVGJlSTg0Y3BDUTE0elYyQlRjb2pEOU9YTWRSRUlNTlhLZDE4QzBhd1hwSUtmRHI2ZnQ2Q2Z4U040eEFxSFd4eVRQS2tURERVb0lyb1RhMXR4dWJIVDFIMHBpVi14a29OcXpxcTNPUUJjT2piQ0YyUmpR?oc=5","date":"2018-09-27","type":"deal","source":"Yahoo Finance","summary":"Alexion (ALXN) to Acquire Biotech Syntimmune for $1.2 Billion - Yahoo Finance","headline":"Alexion (ALXN) to Acquire Biotech Syntimmune for $1.2 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOcmZrSTlzMTh5bGVVdXFYZ0NxQlhPRzlob0tjZ244UkJGb2hUb3MtdF9XSU1obGRYbkF6dHp0bmV1XzdydnV4cU5pMkVPZWlOZHF2NDdpMzRoQ0hKYjJ0SHc1dlZSZWl3MFM1VDVOZi1LcDN2RmwxWERVbl9HU0Z0VFJjc0lOUk9oazVXV21wLWJ3eUoxRDVXcEx0RzJmQTBwanAyX0VXVHZ0dnMxYmc?oc=5","date":"2018-09-26","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Alexion to Acquire Syntimmune for Up to $1.2B, Expanding Rare Disease Pipeline - Genetic Engineering and Biotechnology News","headline":"Alexion to Acquire Syntimmune for Up to $1.2B, Expanding Rare Disease Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOd0dVQXl4V0hlb3lXeWhfREZObFBCWXZlNTZ3b2Y5YjJOcnp1UnRUVTdOR3BnVDYwbTEwdnREUWZyajRSdGdPazlCQkpoc1AyNEhWbEZseFQxbzdySW5wMUVDWHJGZkNDZTZrM1podkIwbTQ3RkVGOF84R05qRzY0eS04aHp2clc1bmlRUTdVam5Mek02UElDSHViZEFFdw?oc=5","date":"2018-09-26","type":"pipeline","source":"Fierce Biotech","summary":"Alexion snaps up another biotech, paying $1.2B for Syntimmune - Fierce Biotech","headline":"Alexion snaps up another biotech, paying $1.2B for Syntimmune","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQVXFhd1NEV3pkMHVyLTlQQWRtUkNDbWpzMVRVTkpkSzZDVGwxb0RzLUpCZWdlcVVNRFRBNjVVakhUVGhpSy1URk82VkJsYmJoZzZjckRVOXpPRG1pS2lSaGR0YXl1cEx5UDlPYWVnd21mZzBhZVktc3FNelZWSUV5a0ZFVkVoaGt3MlYzSmptTktWbkQ2UnctOXlrdEU0SmdKNWZFd1N5Zw?oc=5","date":"2018-09-26","type":"deal","source":"The Business Journals","summary":"Alexion to acquire Boston startup Syntimmune for up to $1.2B - The Business Journals","headline":"Alexion to acquire Boston startup Syntimmune for up to $1.2B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPV1hjVUFYRVFIWVc1LXFYbmNIUXItdnhiR1p1VEplTHJMQlVGMHVuUFNXc0llQVljSW1OMUdnWFZScy1rSlFEend4NHF1a2dJUXBiTjdyaHRVeXM3cG9UM2JJX3J4Y05SbVoxc2g1VDNaYm9SUlluUDVzRUxnYkRZNWdQaXg1ZmFxMVR6b0ZOSWFGVGtTbHFlYmVibkF5NE1Id2RyTTVTSDVSUQ?oc=5","date":"2018-07-09","type":"pipeline","source":"Fierce Biotech","summary":"Syntimmune picks up Vertex VP for CMO as leadership changes continue - Fierce Biotech","headline":"Syntimmune picks up Vertex VP for CMO as leadership changes continue","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}